Mary Beth Nierengarten

Troubles With Drug Pricing Transparency
07/18/2019
Experts discuss the complications of drug pricing transparency, focusing on the rule requiring drug manufacturers to disclose list prices in TV advertisements, which has since been blocked by a federal judge.
Experts discuss the complications of drug pricing transparency, focusing on the rule requiring drug manufacturers to disclose list prices in TV advertisements, which has since been blocked by a federal judge.
Experts discuss the...
07/18/2019
First Report Managed Care
Look to Benefit Design Trends of Exchange Market for Formulary Management
07/30/2015
“Although the exchange market is still small, it is important for the managed care industry to be on the forefront of trends in formulary management,” said Caroline Pearson, vice president, health reform and policy, Avalere Health,...
“Although the exchange market is still small, it is important for the managed care industry to be on the forefront of trends in formulary management,” said Caroline Pearson, vice president, health reform and policy, Avalere Health,...
“Although the exchange market is...
07/30/2015
First Report Managed Care
Self-injected SC versus IV Biologic Agents for RA
05/17/2013
Based on a new claims-based algorithm developed to evaluate the effectiveness of biologics for rheumatoid arthritis (RA), self-injected subcutaneous (SC) first-line biologic agents are more effective than intravenous (IV) administered agents...
Based on a new claims-based algorithm developed to evaluate the effectiveness of biologics for rheumatoid arthritis (RA), self-injected subcutaneous (SC) first-line biologic agents are more effective than intravenous (IV) administered agents...
Based on a new claims-based...
05/17/2013
First Report Managed Care
TNF Antagonists and Cardiovascular Disease Risk
02/22/2012
Chicago—Data from a large epidemiologic study presented at the ACR meeting suggest a trend toward reduced cardiovascular disease (CVD) risk among patients with rheumatoid arthritis (RA) during the first 6 months of initiating treatment with...
Chicago—Data from a large epidemiologic study presented at the ACR meeting suggest a trend toward reduced cardiovascular disease (CVD) risk among patients with rheumatoid arthritis (RA) during the first 6 months of initiating treatment with...
Chicago—Data from a large...
02/22/2012
First Report Managed Care
Newsfeed
Reducing Variability and Cutting Cost Through Utilization Metrics and Transparency
03/09/2016
“In the age of value-based purchasing, health care institutions must demonstrate high-quality care to improve overall value to the patients they serve,” said Barbara Strain, MA, CVAHP, director value management, University of Virginia Health...
“In the age of value-based purchasing, health care institutions must demonstrate high-quality care to improve overall value to the patients they serve,” said Barbara Strain, MA, CVAHP, director value management, University of Virginia Health...
“In the age of value-based...
03/09/2016
First Report Managed Care
Cover Story
Threat of Gun Violence Goes Beyond Individual Health
08/02/2022
With the rise of gun violence across the United States, health care professionals and stakeholders across the continuum of care are calling out for recognition of gun violence as a public health issue.
With the rise of gun violence across the United States, health care professionals and stakeholders across the continuum of care are calling out for recognition of gun violence as a public health issue.
With the rise of gun violence...
08/02/2022
First Report Managed Care
Experimenting With Nonmedical Benefits to Improve Outcomes
07/05/2018
What the US health care system does not primarily focus on, is how to maintain and improve the health of individuals through services that are not directly linked to a medical need.
What the US health care system does not primarily focus on, is how to maintain and improve the health of individuals through services that are not directly linked to a medical need.
What the US health care system...
07/05/2018
First Report Managed Care
Cost-Effectiveness of Dalteparin versus Heparin for VTE
02/17/2015
Low-molecular-weight heparin dalteparin is more effective with similar or lower costs than unfractionated heparin for the prevention of venous thromboembolism.
Low-molecular-weight heparin dalteparin is more effective with similar or lower costs than unfractionated heparin for the prevention of venous thromboembolism.
Low-molecular-weight heparin...
02/17/2015
First Report Managed Care
Tofacitinib Monotherapy for RA versus Risk of Adverse Events
12/17/2012
Results of a phase 3, double-blind, placebo-controlled study [N Engl J Med. 2012;367(6):495-507] show that tofacitinib monotherapy is associated with a reduction in signs and symptoms of rheumatoid arthritis (RA) and improvement in physical...
Results of a phase 3, double-blind, placebo-controlled study [N Engl J Med. 2012;367(6):495-507] show that tofacitinib monotherapy is associated with a reduction in signs and symptoms of rheumatoid arthritis (RA) and improvement in physical...
Results of a phase 3,...
12/17/2012
First Report Managed Care
Feature
Frequent Exacerbations in Patients with COPD May Indicate a Distinct Susceptibility Phenotype
01/04/2011
Results of an observational study [N Engl J Med. 2010;363(12):1128-1138] suggest that patients with chronic obstructive pulmonary disease (COPD) who have more frequent exacerbations appear to have a distinct susceptibility phenotype that is...
Results of an observational study [N Engl J Med. 2010;363(12):1128-1138] suggest that patients with chronic obstructive pulmonary disease (COPD) who have more frequent exacerbations appear to have a distinct susceptibility phenotype that is...
Results of an observational...
01/04/2011
First Report Managed Care

Upcoming Events

February 2 ⁠–⁠ February 5
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
SAWC Spring
April 30 ⁠–⁠ May 4
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 5
WoundCon
May 1 ⁠–⁠ May 3
Senior Living Executive Conference
May 19 ⁠–⁠ May 21
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use